Evidence-based recommendations on semaglutide (Wegovy) for managing overweight and obesity in adults. Commercial availability The Wegovy brand of semaglutide is not commercially available yet....

Texto completo (enlace principal)     Texto completo (enlace alternativo)    

Overweight and obesity are an increasing health problem of the population all over the world, including in Estonia. According to the data of the Estonian adult population health behavior survey conducted in 2018, 40% of Estonian men and 26% of women are overweight, and 21% of men and 18% of women are obe...

Texto completo

Saudi med. j; 37 (10), 2016

OBJECTIVE: To assist healthcare providers in evidence-based clinical decision-making for the management of overweight and obese adults in Saudi Arabia. METHODS: The Ministry of Health, Riyadh, Kingdom of Saudi Arabia assembled an expert Saudi panel to produce this clinical practice guideline in 2015. In ...

Texto completo